Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Validation and Final Results from the First Cardiac Lead Post-Approval Study Using Real-World Data.

PMID: 39720009 ·

Steven Mullane, Jacob B Hicks, Kazi Sharmin, Camden Harrell, Angie Rock, Crystal Miller

JournalPragmatic and observational research
Year
PMID39720009

Abstract

As part of Electrophysiology Predictable and Sustainable Implementation of National Registries (EP PASSION), a multi-stakeholder collaboration between the US Food and Drug Administration (FDA), academic and society partners, and cardiovascular implantable electronic device manufacturers, a 5-year bradycardia lead study transitioned from a traditional post-approval study (PAS) to a real-world data (RWD) approach using a novel method to evaluate chronic cardiac lead complications. Lead complicatio

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.